title: Hyponatraemic seizure following arginine vasopressin for von Willebrand disease: pernicious, predictable and preventable.
authors.affiliation: Department of Endocrinology, Canterbury District Health Board, Christchurch, New Zealand.
authors.forename: T J
authors.initials: TJ
authors.lastname: Upton
authors.forename: P J
authors.initials: PJ
authors.lastname: Hunt
authors.forename: M P
authors.initials: MP
authors.lastname: Doogue
mesh_terms: D000368:Aged; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004231:Diuresis; D004305:Dose-Response Relationship, Drug; D004326:Drinking; D017558:Elective Surgical Procedures; D005260:Female; D006282:Health Personnel / Q000193:education; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000150:complications / Q000601:surgery; D007010:Hyponatremia / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control; D016105:Parathyroidectomy; D011183:Postoperative Complications / Q000139:chemically induced* / Q000517:prevention & control; D012640:Seizures / Q000209:etiology*; D014842:von Willebrand Diseases / Q000188:drug therapy*
chemical_list: D003894:Deamino Arginine Vasopressin